THOMAS MCNERNEY & PARTNERS LP

Track

Insider profile

Performance

Overall performance
3.4
Performance over holding periods
3.4
30 days 90 days 120 days
Average return 85% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
6 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
THOMAS MCNERNEY & PARTNERS LP's trades of Clarus Therapeutics Holdings Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2022-04-21 2022-04-20
S Sale
25,943 -14.4%
92.69
US$3,575,268 		25,943 -14.4% 92.69 US$3,575,268
2022-04-21 2022-04-20
S Sale
99,775 -25.7%
406.69
US$3,732,540 		99,775 -25.7% 406.69 US$3,732,540
2022-04-21 2022-04-20
S Sale
89,526 +8.6%
267.16
US$3,376,423 		89,526 +8.6% 267.16 US$3,376,423
2022-04-21 2022-04-20
S Sale
5,722 -68.3%
2.53
US$14,477 		5,722 -68.3% 2.53 US$14,477
2022-04-21 2022-04-20
S Sale
2,061,685 -68.3%
2.53
US$5,216,063 		2,061,685 -68.3% 2.53 US$5,216,063
2022-04-21 2022-04-20
S Sale
1,663,126 -68.3%
2.53
US$4,207,709 		1,663,126 -68.3% 2.53 US$4,207,709